Low Back Pain – Pipeline Review, H2 2019

“Global Markets Direct’s, ‘Low Back Pain – Pipeline Review, H2 2019’, provides an overview of the Low Back Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Low Back Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Low Back Pain and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.”

Scope


– The report provides a snapshot of the global therapeutic landscape of Low Back Pain

– The report reviews pipeline therapeutics for Low Back Pain by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Low Back Pain therapeutics and enlists all their major and minor projects

– The report assesses Low Back Pain therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Low Back Pain”

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Low Back Pain

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Low Back Pain pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

“Ache Laboratorios Farmaceuticos SA

Adynxx Inc

Allodynic Therapeutics LLC

AnGes Inc

Axsome Therapeutics Inc

BioRestorative Therapies Inc

Bol Pharma

Camurus AB

Daewon Pharmaceutical Co Ltd

Frontier Biotechnologies Inc

Gador SA

Grunenthal GmbH

Hisamitsu Pharmaceutical Co Inc

Imbrium Therapeutics LP

Immune Pharmaceuticals Inc

Inspyr Therapeutics Inc

Intec Pharma Ltd

MD Biosciences GmbH

Mesoblast Ltd

Navipharm Co Ltd

Nektar Therapeutics

Pacira BioSciences Inc

Pfizer Inc

Qingdao Chia Tai Haier Pharmaceutical Co Ltd

Scilex Holding Co

Stayble Therapeutics AB

Sun Pharma Advanced Research Company Ltd

Therapix Biosciences Ltd

WEX Pharmaceuticals Inc”

Table of Contents

Table of Contents

Table of Contents 2

Introduction 5

Low Back Pain Overview 6

Low Back Pain Therapeutics Development 7

Low Back Pain Therapeutics Assessment 13

Low Back Pain Companies Involved in Therapeutics Development 21

Low Back Pain Drug Profiles 31

Low Back Pain Dormant Projects 95

Low Back Pain Discontinued Products 97

Low Back Pain Product Development Milestones 98

Appendix 109

List of Tables

“List of Tables

Number of Products under Development for Low Back Pain, H2 2019

Number of Products under Development by Companies, H2 2019

Number of Products under Development by Companies, H2 2019 (Contd..1), H2 2019

Products under Development by Companies, H2 2019

Products under Development by Companies, H2 2019 (Contd..1), H2 2019

Number of Products by Stage and Target, H2 2019

Number of Products by Stage and Target, H2 2019 (Contd..1), H2 2019

Number of Products by Stage and Mechanism of Action, H2 2019

Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..1), H2 2019

Number of Products by Stage and Route of Administration, H2 2019

Number of Products by Stage and Molecule Type, H2 2019

Low Back Pain – Pipeline by Ache Laboratorios Farmaceuticos SA, H2 2019

Low Back Pain – Pipeline by Adynxx Inc, H2 2019

Low Back Pain – Pipeline by Allodynic Therapeutics LLC, H2 2019

Low Back Pain – Pipeline by AnGes Inc, H2 2019

Low Back Pain – Pipeline by Axsome Therapeutics Inc, H2 2019

Low Back Pain – Pipeline by BioRestorative Therapies Inc, H2 2019

Low Back Pain – Pipeline by Bol Pharma, H2 2019

Low Back Pain – Pipeline by Camurus AB, H2 2019

Low Back Pain – Pipeline by Daewon Pharmaceutical Co Ltd, H2 2019

Low Back Pain – Pipeline by Frontier Biotechnologies Inc, H2 2019

Low Back Pain – Pipeline by Gador SA, H2 2019

Low Back Pain – Pipeline by Grunenthal GmbH, H2 2019

Low Back Pain – Pipeline by Hisamitsu Pharmaceutical Co Inc, H2 2019

Low Back Pain – Pipeline by Imbrium Therapeutics LP, H2 2019

Low Back Pain – Pipeline by Immune Pharmaceuticals Inc, H2 2019

Low Back Pain – Pipeline by Inspyr Therapeutics Inc, H2 2019

Low Back Pain – Pipeline by Intec Pharma Ltd, H2 2019

Low Back Pain – Pipeline by MD Biosciences GmbH, H2 2019

Low Back Pain – Pipeline by Mesoblast Ltd, H2 2019

Low Back Pain – Pipeline by Navipharm Co Ltd, H2 2019

Low Back Pain – Pipeline by Nektar Therapeutics, H2 2019

Low Back Pain – Pipeline by Pacira BioSciences Inc, H2 2019

Low Back Pain – Pipeline by Pfizer Inc, H2 2019

Low Back Pain – Pipeline by Qingdao Chia Tai Haier Pharmaceutical Co Ltd, H2 2019

Low Back Pain – Pipeline by Scilex Holding Co, H2 2019

Low Back Pain – Pipeline by Stayble Therapeutics AB, H2 2019

Low Back Pain – Pipeline by Sun Pharma Advanced Research Company Ltd, H2 2019

Low Back Pain – Pipeline by Therapix Biosciences Ltd, H2 2019

Low Back Pain – Pipeline by WEX Pharmaceuticals Inc, H2 2019

Low Back Pain – Dormant Projects, H2 2019

Low Back Pain – Dormant Projects, H2 2019 (Contd..1), H2 2019

Low Back Pain – Discontinued Products, H2 2019”

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports